Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. (2015)
Attributed to:
Immunity in the face of diversity and the development of novel potent HCV vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1053/j.gastro.2015.07.043
PubMed Identifier: 26248087
Publication URI: http://europepmc.org/abstract/MED/26248087
Type: Journal Article/Review
Volume: 149
Parent Publication: Gastroenterology
Issue: 6
ISSN: 0016-5085